4 completed, 1 recruiting. 4 Phase 1, 1 Phase 2.
By phase and status
Follow PF-08049820: new trials by email Literature Review of PF-08049820 trials Research Report on PF-08049820
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults
PF-08049820, Rabeprazole - Healthy Adults, Healthy | Phase 1 | Completed | Pfizer | 24 | 2026-05-13 | 2026-10-01 |
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
PF-08049820, Placebo - Atopic Dermatitis, Eczema, Atopic | Phase 2 | Recruiting | Pfizer | 165 | 2025-11-20 | 2026-10-13 |
A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.
PF-08049820, Rabeprazole - Healthy Adults | Phase 1 | Completed | Pfizer | 18 | 2025-11-03 | 2026-09-09 |
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
PF-08049820, Midazolam, Dabigatran Etexilate - Atopic Dermatitis | Phase 1 | Completed | Pfizer | 16 | 2025-10-03 | 2026-09-09 |
A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy Adults
PF-08049820, Placebo - Healthy | Phase 1 | Completed | Pfizer | 71 | 2024-11-27 | 2026-09-08 |
Conditions studied
Dermatitis, Atopic (4) · Eczema (1)
Sponsors
Pfizer (5)
Countries
United States (4) · China (2) · Bulgaria (1) · Canada (1) · Czechia (1) · France (1) · Japan (1) · Poland (1)
NIH funding
2025 (1)